R

Redhill Biopharma Ltd
D

RDHL

1.84000
USD
-0.01
(-0.54%)
مغلق
حجم التداول
219
الربح لكل سهم
-1
العائد الربحي
-
P/E
-0
حجم السوق
3,255,181
أصول ذات صلة
A
AKRO
-2.565
(-5.24%)
46.380 USD
A
ALLO
-0.05500
(-5.02%)
1.04000 USD
D
DRRX
-0.03100
(-5.47%)
0.53590 USD
G
GNFT
0.09000
(2.13%)
4.32000 USD
I
IMUX
-0.00820
(-0.89%)
0.91510 USD
K
KALA
-0.10000
(-2.53%)
3.86000 USD
R
RCKT
-0.28500
(-4.35%)
6.26500 USD
S
SNGX
-0.02000
(-1.09%)
1.81000 USD
المزيد
الأخبار المقالات

العنوان: Redhill Biopharma Ltd

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-relatedproducts in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.